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SUMMARY

The regulation and stem cell origin of normal and neoplastic gastric glands are uncertain. Here, we show that
Mist1 expression marks quiescent stem cells in the gastric corpus isthmus. Mist1+ stem cells serve as a cellof-origin for intestinal-type cancer with the combination of Kras and Apc mutation and for diffuse-type cancer
with the loss of E-cadherin. Diffuse-type cancer development is dependent on inflammation mediated by
Cxcl12+ endothelial cells and Cxcr4+ gastric innate lymphoid cells (ILCs). These cells form the perivascular
gastric stem cell niche, and Wnt5a produced from ILCs activates RhoA to inhibit anoikis in the E-cadherindepleted cells. Targeting Cxcr4, ILCs, or Wnt5a inhibits diffuse-type gastric carcinogenesis, providing targets within the neoplastic gastric stem cell niche.

INTRODUCTION
Gastric cancer is the third most frequent cause of cancer death
worldwide. In the gastric corpus within the proximal stomach,
the glands contain chief cells that are important for digestion,

and parietal cells that are vital for acid production, controlled in
part by enterochromaffin-like (ECL) cells. There are also intervening mucous neck cells, above which are the superficial pits
that are lined by pit cell epithelium. Despite abundant literature
on small intestinal stem cells (ISCs), an infrequent site of human

Significance
We identified a quiescent stem cell in the corpus isthmus, which can give rise to gastric cancer. We also discovered a
Cxcl12/Cxcr4 perivascular niche in the stomach, which supports normal and neoplastic stem cells through Wnt5a
production.
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cancer, there have been relatively few studies addressing the
stem cells that maintain the normal and neoplastic gastric
epithelium.
Tissue stem cells maintain the integrity of rapidly proliferating
tissues such as the gastrointestinal epithelium, residing within a
stem cell niche. Replicative quiescence and a relatively undifferentiated morphology have generally been considered cardinal
properties of adult stem cells (Malam and Cohn, 2014; Mills
and Shivdasani, 2011). In the gastric corpus, earlier radiolabeling
and electron microscopy studies suggest a single undifferentiated, ‘‘granule free’’ cell as the putative stem cell in the isthmus
of each gastric unit of the mouse (Karam and Leblond, 1993;
Mills and Shivdasani, 2011). Studies suggest that within the
corpus isthmus, Sox2+ cells may be long-lived stem cells, while
Tff2+ cells are relatively short-lived progenitors (Arnold et al.,
2011; Quante et al., 2010). More recently, a ‘‘reserve stem-like
cell’’ population expressing Troy or Mist1 was postulated to
reside at the base of corpus gland (Stange et al., 2013).
Gastric cancer is classified into an intestinal-type and a
diffuse-type, and carcinogenesis in the stomach is strongly
associated with chronic inflammation. Oncogenic mutations
such as Kras and Apc targeted to gastric stem/progenitor
cells led to intestinal-type metaplasia or dysplasia in mice
(Barker et al., 2010; Okumura et al., 2010). By contrast, the Ecadherin gene (CDH1) is frequently mutated or downregulated
in diffuse-type gastric cancer (DGC) (Guilford et al., 1998). In a
rodent model, knock out of Cdh1 was insufficient to initiate
gastric tumors, but did predispose to the development of DGC
with signet-ring cells following additional genetic events (Shimada et al., 2012). Studies of prophylactic gastrectomy specimens from germline carriers of CDH1 mutations have revealed
that DGC appears to arise in the proximal gastric isthmus (Humar
et al., 2007), but the cellular origin of all gastric cancers remains
unknown.
Tissue stem cells and cancer development are maintained by
their niche. The Wnt signaling pathway plays a central role in the
maintenance of ISCs, which are supported by the ISC niche,
including both Paneth cells (Sato et al., 2011) and the surrounding mesenchyme (Farin et al., 2012). However, the gastric corpus
does not normally depend on the Wnt pathway (Mills and Shivdasani, 2011), and therefore the critical pathway regulating corpus
stem cell niche is largely unknown. In the gut mesenchyme,
several cell types including pericytes, nerves, or mesothelial cells

(Miyoshi et al., 2012; Worthley et al., 2015; Zhao et al., 2014) are
reported to maintain tissue stem cells and contribute to cancer
development. In the bone marrow, perivascular stromal cells
including endothelial cells, Cxcl12-abundant reticular (CAR)
cells, and nerves, promote hematopoietic stem cell (HSC) maintenance and neoplastic changes through the production of cytokines or chemokines such as Cxcl12 or SCF (Hanoun et al., 2014;
Mendelson and Frenette, 2014; Pitt et al., 2015). However,
whether such stromal factors play a role in the normal and
neoplastic gut stem cell niche remains unclear.
RESULTS
Mist1 Is a Marker of Quiescent Stem Cells in the Gastric
Corpus Isthmus
We utilized Mist1-CreERT2 knockin mice, where Cre recombinase is induced by tamoxifen (TAM) in cells expressing a bHLH
transcription factor Mist1, and investigated the contribution of
Mist1+ reserve stem-like chief cells to gastric carcinogenesis.
To clarify the expression pattern of Mist1 in the normal stomach,
we crossed Mist1-CreERT2 mice with R26-mTmG mice.
This reporter features the dichotomous expression of red
(without recombination) or green fluorescence (with recombination). Most of the recombined Mist1+ cells were detected in
mature chief cells in the lower third of the glands (position
1–14) 1 day after TAM induction (Figure 1A). However, Mist1+ recombined cells were also evident as rare single cells in the
isthmus. Recombination in the isthmus was observed in either
R26-TdTomato or R26-LacZ mice, or with low dose TAM
(1 mg) (Figure S1A). Endogenous Mist1 expression in the isthmus
was confirmed by in situ hybridization (Figure S1B). Their electron microscopy appearance was similar to the granule free
stem cells previously reported (Karam and Leblond, 1993)
(Figure 1B).
The GFP+ Mist1 lineage expanded gradually over 540 days
(Figures 1C and 1D). In contrast to a previous report (Stange
et al., 2013), our detailed time course revealed bi-directional
expansion from single Mist1+ cells at position 25–30 in the
isthmus, both upward toward the lumen and deeper into the
gland, independent of the dose of TAM (Figure S1C). The
approximate doubling time of Mist1+ isthmus cells is 120 hr or
5 days (Figure S1D), and these cells first divided into isthmus
progenitors with small or spindle appearance (Figure S1E),

Figure 1. Mist1 Is a Marker of Quiescent Stem Cells in the Corpus Isthmus
(A) The corpus of Mist1-CreERT2;R26-mTmG mice day 1 after 3 mg TAM. The left image shows chief cells and the right image shows isthmus cells (arrow).
(B) Electron microscopy of Mist1+ cells in the isthmus.
(C) Lineage tracing in Mist1-CreERT2;R26-mTmG mice from day 1–540. The arrow indicates the isthmus cells.
(D) Mist1-traced cell position. The total 50 glands are analyzed at each time point.
(E) The number of traced glands per 100 glands at 3, 6, and 12 months. The total 300 glands from three mice are used at each time point.
(F and G) Mist1-CreERT2;R26-Confetti mice 8 months after TAM (F). The single color and multi-color clones in the isthmus and chief cells are quantified (G). The
total 50 glands are analyzed.
(H and I) Mist1-CreERT2;Lgr5-DTR-GFP (green);R26-TdTomato (red) mouse corpus 24 hr after TAM (H) and 2, 5, 10, and 180 days after TAM + DT ablation (I). The
yellow arrows show Mist1+ isthmus cell tracing and the green arrows show Lgr5+ chief cells.
(J and K) The numbers of labeled chief cells per gland (J, day 4) and lineage tracing events per 100 glands (K, day 30) with or without DT ablation.
(L) Lineage tracing in 5-FU-treated Mist1-CreERT2;R26-mTmG mouse corpus (refer to Figure 1C for control images).
(M and N) The numbers of labeled chief cells per gland 4 days after TAM (cont) or TAM + 5-FU (5-FU) treatments (M) and the number of lineage tracing events per
100 glands on day 30 (N). The total 500 glands from five mice/group are analyzed for (J), (K), (M), and (N). Scale bars represent 1 mm (B) and 10 mm (A, C, F, H, I, and
L) (means ± SEM) (*p < 0.05).
See also Figure S1.
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followed later by the differentiation into surface pit and neck
cells and subsequently into parietal cells. Over time, the number of GFP+ cells in the chief cell region declines while the
isthmus clone expands (Figure 1D). Lineage tracing persisted
beyond 18 months post-induction with whole labeled corpus
glands, proving that Mist1+ cells self-renew (Figure 1E). Mist1CreERT2;R26-Confetti mice show that single-color clonal
expansion is seen predominantly in the isthmus area, while chief
cells show scattered multi-color labeling (Figures 1F and 1G).
These data indicate that the Mist1+ isthmus cell is the major
source of lineage tracing of corpus glands.
In this period, Mist1+ cells gave rise to mucus neck cells (GSII), parietal cells (H/K-ATPase), surface pit cells (TFF1), tuft cells
(Dclk1), and ECL cells (chromogranin A), while initially Mist1+
cells were negative for these markers (Figures S1F and S1G).
Mist1+ chief cells at the base of glands are as expected positive
for GIF at day 2 after TAM, while the Mist1+ isthmus cells are GIFnegative (Figure S1H). However, the early traced GIF+ chief cells
at the base of glands decreased over time with an increase of
traced GIF isthmus cells (Figures S1I and S1J). Thus, Mist1+
basal chief cells are labeled by initial TAM induction, but these
cells turn over and disappear, finally to be renewed from the
isthmus-derived Mist1+ stem cell.
Mist1+ Isthmus Cells Are Responsible for Gastric
Lineage Tracing
We confirmed no overlap between Mist1+ cells and reported
gastric stem cell markers Cckbr+ or Sox2+ (Arnold et al., 2011;
Hayakawa et al., 2015) (Figures S1K and S1L). Since chief cells
have also been shown to be Lgr5+ (Stange et al., 2013), we
generated Mist1-CreERT2;Lgr5-DTR-GFP;R26-Tdtomato mice
(Tian et al., 2011). Similar to GIF staining, the vast majority of
Mist1+ chief cells at the base are Lgr5+, whereas the Mist1+
isthmus cells are Lgr5 (Figure 1H). Thus, we ablated Lgr5+ cells,
which included Mist1+ chief cells, by administration of diphtheria
toxin (DT) (Figure S1M). After giving TAM and DT, 100% of
labeled chief cells were ablated (Figures 1I, 1J, and S1N). The
expression of Lgr5 or Gif was markedly reduced by DT ablation
(Figure S1O). However, the number of isthmus Mist1+ cells was
even increased and lineage tracing occurred at the same frequency as the control (non-DT) group, accompanied with faster
cell division (Figures 1I, 1K, and S1P–S1S). After 6 months, the
isthmus Mist1+ cells gave rise to chief cells. Similarly, ablation
of chief cells by the elastase inhibitor DMP-777 (Nomura et al.,
2005) did not affect the frequency of lineage tracing (Figures
S1T–S1W). In contrast, when we treated mice with 5-Fluorouracil
(5-FU) to kill isthmus stem/progenitor cells (Figures S1X and
S1Y) (Stange et al., 2013), the mice showed almost no lineage
tracing events, but maintained a similar number of labeled chief
cells at the gland base for 6 months (Figures 1L–1N). Thus,
Mist1+ isthmus cells, and not Mist1+ chief cells, are responsible
for lineage tracing in the corpus.
Isthmus Mist1+ Cells Give Rise to Intestinal-type
Metaplasia and Cancer
In the isthmus, 1.1% of the Mist1+ cells were Ki67+ (Figure 2A),
thus, more than 98% of Mist1+ isthmus stem cells are quiescent.
KRAS is one of the most commonly mutated proto-oncogenes in
a variety of cancers, including gastric cancer. To investigate the

effect of Kras mutation in gastric stem cells, we crossed Mist1CreERT2 mice to LSL-KrasG12D mutant mice. Kras mutation in
Mist1+ isthmus cells resulted in an increased percentage of
Ki67+Mist1+ cells and overall faster cell division (Figures S2A–
S2C). These cells formed Ki67+ dysplastic foci in the isthmus,
which contained Alcian blue positive metaplastic cells (Figures
2B–2D). The metaplastic/dysplastic foci moved from the isthmus
to the bottom of glands with loss of parietal cells and chief cells
and eventually replaced the entire glands with intestinal metaplasia (IM) and dysplasia (Figure S2D). We generated Mist1CreERT2;LSL-KrasG12D;Lgr5-DTR mice and ablated isthmus
cells and chief cells by giving 5-FU and DT, accordingly, after
TAM induction (Figure S2E). Strikingly, 5-FU inhibited the metaplasia development, while DT ablation did not (Figures 2E and
2F), indicating that the Mist1+ isthmus cells, and not the Mist1+
chief cells, are an origin of Kras-induced IM and dysplasia.
Aberrant activation of the Wnt signaling pathway by inactivating Apc is a common initiating event in many gastrointestinal
tumors (Barker et al., 2009, 2010). Thus, we established Mist1CreERT2;Apcflox/flox mice. Nuclear accumulation of b-catenin
was observed in the Mist1+ lineage (isthmus and chief cells).
However, nuclear b-catenin+ cells in corpus Mist1+ cells did
not form dysplasia at later time points (up to 8 months) (Figures
2G and 2H), which seems contrary to the phenotype of Apc
loss in stem cells in the gastric antrum, small intestine, and colon.
In fact, whereas Wnt inhibition by Dickkopf-1 (DKK1) overexpression leads to marked decrease in proliferation in the intestine and colon, proliferation in the corpus was not inhibited
(Figures S2F and S2G), suggesting that tumor initiation or proliferation in the corpus is likely independent of Wnt/b-catenin
signaling.
IM in the stomach is a known risk factor or precursor lesion for
intestinal-type gastric cancer (IGC). Thus, we attempted to
induce Wnt/b-catenin activation in the presence of IM. We
generated Mist1-CreERT2;LSL-KrasG12D;Apcflox/flox mice, and
this mouse developed intramucosal IGC with the expansion of
nuclear b-catenin+ cells in 4 months (Figure 2I). Thus, Mist1+
stem cells can give rise to IGC with loss of Apc only when
Kras-induced IM is also present. Notch signaling is another
important pathway regulating gastric proliferation (Kim and Shivdasani, 2011). The Notch inhibitor dibenzazepine (DBZ) reduced
the expansion of Mist1-lineage tracing as well as proliferation in
the isthmus (Figures S2H–S2K), and constitutive activation of
Notch signaling in Mist1+ stem cells by generating Mist1-CreERT2;Eef1a1-LSL-Notch1(IC) mice (Buonamici et al., 2009) resulted
in the development of IGC (Figure S2L). Although Mist1 protein
expression is decreased in Kras/Apc-induced IGC, aberrant
Notch activation increased the number of Mist1+ cells in the
tumor (Figures S1Q and S2M). The dysplastic cells in Notchinduced tumor did not display nuclear b-catenin accumulation,
suggesting that in the corpus, Notch signaling is a Wnt-independent oncogenic pathway through which Mist1+ stem cells can
progress to IGC.
Mist1+ Isthmus Cells Can Form Corpus Organoids in a
Lgr5-Independent Fashion
To evaluate the stem cell properties of Mist1+ cells in vitro, we
isolated corpus glands from Mist1-CreERT2;R26-mTmG mice
1 day following TAM induction. Mist1+ green cells were observed
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Figure 2. Mist1+ Isthmus Cells Give Rise to IM and IGC
(A) Ki67 (red) and GFP staining (green) of Mist1-CreERT2;R26-mTmG mice at day 2.
(B–D) Hematoxylin and eosin (H&E) (B), Ki67 (C), and Alcian blue (D) staining in Mist1-CreERT2;LSL-KrasG12D mice on days 14, 21, and 28 after induction. The
arrows indicate isthmus-derived dysplastic cells.
(E and F) H&E staining (E) and numbers of metaplastic glands per 100 glands (F) of Mist1-CreERT2;LSL-KrasG12D;Lgr5-DTR-GFP mice treated with PBS (left),
5-FU (middle), or DT (right) 30 days after TAM. The total 300 glands from three mice/group are analyzed.
(G and H) H&E (G, day 240) and b-catenin (H) staining in Mist1-CreERT2;Apcflox/flox mouse. The arrows indicate the nuclear b-catenin+ cells.
(I) H&E (left) and b-catenin (right) staining in Mist1-CreERT2;LSL-KrasG12D;Apcflox/flox mouse corpus on day 120 post-induction (means ± SEM) (*p < 0.05). Scale
bars represent 10 mm (A) and 100 mm (B–E and G–I).
See also Figure S2.

in the two distinct positions, and Mist1+ isthmus cells expanded
to form cystic organoids in the reported culture method (Stange
et al., 2013), while Mist1+ chief cells remained as single cells and
eventually disappeared (Figure 3A). The GFP+ Mist1-derived
cells survived in vitro for at least 2 months, confirming longevity.
Even after ablation of Lgr5+ chief cells in Mist1-CreERT2;Lgr5DTR;R26-TdTomato mice by DT injection, isthmus Mist1+ cells
continued to lineage trace and give rise to chief cells in cultured
organoids (Figures 3B and 3C). We next sorted Mist1+ cells after
DT or 5-FU treatment to the mice (lacking chief cells and isthmus
cells, respectively) (Figures 3D–3F). Colony formation efficiency

increased in the DT-treated group and decreased in the 5-FUtreated group, suggesting that isthmus Mist1+ cells are the true
corpus stem cells, rather than Mist1+ chief cells. We compared
gene expression patterns between the total Mist1+ population
(majority of which were chief cells), DT-ablated isthmus Mist1+
population, and the differentiated parietal cell population (Figure S3A). Lgr5 and Gif expression are markedly downregulated
in isthmus Mist1+ cells compared to total Mist1+ cells. Mist1
expression is upregulated in both total and isthmus Mist1+ population. The expression of several stem/progenitor markers,
such as Cd44 and Sox9, or target genes of Wnt and Notch
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Figure 3. Mist1+ Isthmus Cells Can Form Corpus Organoids in a Lgr5-Independent Fashion
(A) Corpus gland culture of TAM-induced Mist1-CreERT2;R26-mTmG mice. The yellow arrows show isthmus cells and the white arrows show chief cells.
(B and C) Lineage tracing (B) and GIF staining (C, green) of corpus gland culture from Mist1-CreERT2;Lgr5-DTR-GFP;R26-TdTomato mice treated with DT.
(D–F) TdTomato+ cells were sorted and cultured from DT or 5-FU-treated Mist1-CreERT2;Lgr5-DTR-GFP;R26-TdTomato mice corpus after TAM. The FACS plot
(D), images (E), and the colony formation efficiency (F) at day 7 are shown (n = 4/group).
(G) Relative gene expression per Gapdh in antral or corpus organoids cultured with the indicated media for 10 days (n = 3/group).
(H and I) Organoid growth of antrum and corpus glands cultured with W3aENR or ENJ media. The day 10 images (H) and the relative numbers of organoids
cultured in the indicated media (I) are shown. The numbers in non-DT organoids in each group are set as 1.0 (n = 3/group) (means ± SEM) (*p < 0.05). Scale bars
represent 50 mm.
See also Figure S3.

signaling, such as Ccnd1, Notch1, and Hes1, remain at higher
levels in the isthmus population, suggesting that isthmus
Mist1+ cells are Lgr5 , but still exhibit stem cell characteristics.
The Wnt3a/R-spondin1 (W3a/Rspo1)-dependent culture system fails to produce corpus-specific cell lineage such as parietal
cells and ECL cells (Stange et al., 2013). Instead, W3aENR media
(W3a, EGF, Noggin, and Rspo1) induces marked upregulation of
Lgr5 (three times higher than gastric antrum organoids) (Figure 3G). Compared to standard W3aENR media, culture of
corpus glands in ENJ media (where Wnt3a/Rspo1 were replaced
by Notch ligand Jagged-1) led to decreased expression of Lgr5
or Gif, suggesting that Wnt3a/Rspo1 lead to expansion of chief
cells. In contrast, in ENJ media, we observed greater amounts
of parietal cells and ECL cells than in W3aENR media both in

RT-PCR and immunostaining assays (Figures 3G and S3B), suggesting that the activation of Notch signaling is more important
for preserving mature corpus cell types in culture than canonical
Wnt signaling. Addition of a g-secretase inhibitor blocked corpus
organoid growth (Figures S3C and S3D), thus Notch signaling is
important for corpus stem cell maintenance and growth. When
we cultured Mist1-CreERT2;Lgr5-DTR;R26-TdTomato glands,
antral and corpus organoids cultured with W3aENR did not
grow and died following DT treatment (Figures 3H and 3I), indicating that organoid growth is highly dependent on Lgr5+ cells
in W3aENR media. However, lineage-traced corpus organoids
survived with ENJ plus DT media (Figure S3E), proving that a
non-Lgr5 stem cell population maintains organoid growth in
Wnt3a/Rspo1-independent culture conditions.
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Cxcl12+ Endothelium and Cxcr4+ ILCs Contribute to the
Corpus Stem Cell Niche through Wnt5a Production
Given our in vitro data suggesting that Wnt3a or canonical Wnt
signaling is not a critical niche factor in the corpus, we
explored which Wnt ligands are indeed expressed in the stomach and intestine (Figures 4A and S4A). Among known Wnt
ligands, Wnt3a expression was quite low in the corpus, in
contrast to the intestine. Instead, an atypical Wnt ligand,
Wnt5a, was highly expressed in the corpus. In situ hybridization of Wnt5a revealed focal expression in the isthmus stroma
(Figure 4B) coincident with the known expression of Cxcr4
(Shibata et al., 2013). In Cxcr4-EGFP mice, Cxcr4+ cells were
found in the isthmus area as rare single cells, showing
almost identical distribution to Wnt5a expression (Figure 4C).
Cxcr4+ cells and Mist1+ cells represent distinct populations,
although they were located in close proximity within the
isthmus (Figure 4D).
Immunostaining revealed that Cxcr4+ cells in the corpus are
negative for E-cadherin or stromal markers, aSMA, NG2, and
S100B, but positive for CD45, suggesting that they are tissueresident hematopoietic cells recruited to the isthmus (Figures
4E and S4B). About 60% of gastric CD45+Cxcr4+ cells from
the whole gastric corpus are CD11b+ myeloid lineages (Figure S4C). CD3+ T cells, CD19+ B cells, and NK1.1+ classical
NK cells are Cxcr4 . The remaining 40% of CD45+Cxcr4+ cells
are Lineage-negative (CD3 Gr1 CD11b CD45R Ter119 ) and
about half of the Lin Cxcr4+ population is a CD90.2+CD127+
lymphoid population (Figures 4F and S4C). The other half is predominantly c-kit+FcεRIa+ mast cells. Immunostaining defined
the isthmus Cxcr4+ cells as Lin CD90.2+ intraepithelial gastric
innate lymphoid cells (ILCs) (Figures 4E and S4D). Id2-GFP
mice, which mark all types of ILCs (Hoyler et al., 2012), show a
similar distribution pattern as Cxcr4+ cells (Figure S4E). The
majority (90%) of gastric Cxcr4+ ILCs are NKp46 CD4 ,
ScaI+ICOS+KLRG+ ILC2 cells, and a small population (5%) are
Rorgt+NKp46 ILC3 cells (Figures 4F and S4F). In fact, the
gastric Cxcr4+ ILC population is enriched with ILC2-specific
genes (Figure S4G).
In the sorted Mist1+ cells and Cxcr4+ cells, Wnt5a was expressed primarily in the Cxcr4+ cells (Figures S4H and S4I), confirming our in situ hybridization findings. When we treated Cxcr4+
cells with Cxcl12 in vitro, Wnt5a expression was upregulated
(Figure S4J). We hypothesized that the Cxcr4+ cell might be a
niche cell, supporting gastric stem cell function. To test this
possibility, we performed a co-culture experiment with ‘‘red’’
Mist1+ cells and ‘‘green’’ Cxcr4+ cells. Co-culture of Mist1+ cells
with Cxcr4+ cells significantly enhanced red colony formation
ability (Figures 4G and 4H). Treatment with Cxcl12 demonstrated
an additive effect on Cxcr4+ cell co-culture, while it had no
effect on Mist1+ cell culture alone, indicating that Cxcl12 acts
through the Cxcr4+ ILCs. Furthermore, the Cxcr4+ ILC population exhibits the highest expression of Wnt5a compared to
CD45+Cxcr4 cells or Cxcr4+ non-ILCs (Figure 4I). The colony
formation ability of Mist1+ stem cells is enhanced by Wnt5a or
co-culture with Cxcr4+ ILC population. However, Wnt5a-deficient ILCs which are sorted from Cag-CreERT2;Wnt5aflox/flox
mouse stomach after TAM induction failed to show the same effect (Figure 4J). Thus, Cxcr4+ILC-derived Wnt5a plays a key role
for promoting Mist1+ stem cell colony formation.

We explored the source of Cxcl12 in the stomach. In Cxcl12dsRED mice (Ding and Morrison, 2013), there were frequent
dsRED+ cells in the stroma near the isthmus (Figure 4K). Indeed,
Cxcr4+ ILCs and Cxcl12+ stromal cells in Cxcr4-EGFP;Cxcl12dsRED mice were frequently positioned in close proximity
(Figures 4L and 4M). We confirmed that Cxcl12+ cells are
CD31+ and endomucin+ endothelial cells (Figures 4N and S4K).
We compared RNA expression between dsRED+CD31+ cells
(35% of total CD31+ cells) and dsRED-CD31+ cells by quantitative RT-PCR array (Figure S4L; Table S1). Among pathways
potentially involved in the regulation of Cxcl12 expression, we
found that Cxcl12+ cells express BMP receptor 2, and BMP2
treatment in vitro upregulates Cxcl12 expression (Figures S4M
and S4N), consistent with previous findings (Yang et al., 2008).
Interestingly, Tie2-Cre;Cxcl12flox/flox;Cxcr4-EGFP mice, with targeted knock out of Cxcl12 in endothelial cells, displayed a significant reduction in the number of Cxcr4+ cells in the isthmus
compared to control mice (Figures 4O and 4P). Together, endothelial Cxcl12 is important for the recruitment of Wnt5a-producing Cxcr4+ ILCs in the stomach.
E-cadherin Loss in Mist1+ Cells Develops a Diffuse-type
Cancer Dependent on Chronic Inflammation
We sought to establish whether Mist1+ stem cells were also a cell
of origin for the DGC by knocking out the Cdh1 gene in Mist1+
cells. Mist1-CreERT2;Cdh1flox/flox mice (Cdh1DMist1) developed
the pathognomonic, small mucous-producing atypical cell foci
in the isthmus 10 days after TAM, but not in the chief cell region
(Figures 5A and 5B). E-cadherin was downregulated in these
atypical cells in the isthmus, consistent with early signet-ring
cell morphology, recapitulating the earliest events in the pathogenesis of human signet-ring cell carcinoma. Ablation of chief
cells and isthmus cells by DT and 5-FU treatment with Mist1CreERT2;Cdh1flox/flox;Lgr5-DTR mice confirmed that the isthmus
Mist1+ cells are an origin of signet-ring cells (Figures S5A and
S5B). Cxcl12/Cxcr4 niche cells were not affected by 5-FU treatment (data not shown).
Nevertheless, the number of atypical cells gradually declined
and disappeared (Figure 5C), suggesting that E-cadherin loss
leads to epithelial cell death and is on its own insufficient to
initiate DGC. Given that mild inflammation without gastric atrophy is a common feature of DGC (Carneiro et al., 2004), we infected TAM-induced Cdh1DMist1 mice with Helicobacter felis
(Hf) to induce chronic inflammation. Surprisingly, in mice with
Hf infection, atypical foci were preserved and expanded even after 1 year following TAM induction (Figure 5C). Lineage-traced
DGC with numerous signet-ring cells was detected at 18 months
post Hf infection in Cdh1DMist1 mice (Figure 5D; seven of nine
mice, 78%), along with the increase of Mist1+ cells in DGC (Figures S1Q and S5C). The addition of Trp53 mutation in this setting
led to invasive DGC within 9 months (Figure S5D). Interestingly,
administration of dexamethasone to Hf-infected Cdh1DMist1
mice reduced the number of signet-ring cell foci to the same level
as non-infected control mice (Figures 5E–5G). In contrast,
another inflammation-associated cancer model, H/K-ATPaseIL-1b transgenic mice (Tu et al., 2008), also showed a dramatic
expansion of lineage-traced signet-ring cells when crossed to
Cdh1DMist1 mice, even without Hf infection (Figures 5H–5J).
Thus, DGC development from Mist1+ stem cells is dependent
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Figure 4. Cxcl12+ Vascular Endothelial and Cxcr4+ ILCs Contribute to Corpus Stem Cell Niche through Wnt5a Production
(A) Relative expression of Wnt3 and Wnt5a in the corpus, antrum, and small intestine (n = 3/group).
(B) In situ hybridization of Wnt5a in the corpus. The arrows indicate the Wnt5a-expressing cells in the isthmus stroma.
(C) GFP staining in the Cxcr4-EGFP mouse corpus gland. The arrows indicate the GFP+ cells in the isthmus.
(D) Lineage tracing in Mist1-CreERT2;Cxcr4-EGFP;R26-TdTomato mice on days 2 and 14. The arrows indicate the GFP+ cells.
(E) E-cadherin (red), CD45 (red), Lineage (blue), and CD90.2 (red) staining of Cxcr4-EGFP+ cells.
(legend continued on next page)
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on chronic inflammation and anti-inflammatory therapy may be
useful for preventing DGC.
Although Troy+ chief cells are reported to act as reserve stem
cells (Stange et al., 2013), we observed a rare Troy+ population in
the isthmus that could lineage trace and give rise to cancers by
examining Troy-BAC-CreERT2 mice (Fafilek et al., 2013) (Figures
S6A–S6G). Also, while Troy+ chief cells with intact Troy expression do not proliferate and do not lineage trace, loss of Troy
expression significantly promoted chief cell proliferation and
lineage tracing after injury (Figures S6H–S6L), similar in most respects to the previous report, reconciling our findings with those
of earlier groups (Stange et al., 2013).
Cxcl12/Cxcr4 Perivascular Niche Regulates DGC
Progression through Wnt5a Production
During DGC development under chronic inflammation, corpus
stem cell niche factors—Cxcl12+ endothelium and Cxcr4+
ILCs—are markedly expanded or upregulated in the region surrounding the isthmus DGC lesion (Figures 6A–6E), suggesting
that these niche factors contribute to DGC development. We
tested therapeutic intervention with AMD3100, a specific inhibitor
of CXCR4, and an anti-CD90.2 antibody (Ab) for specific depletion
of ILCs. Compared with vehicle-injected control mice, AMD3100
and the anti-CD90.2 Ab significantly reduced the number of signet-ring cell foci (Figures 6F–6H). In contrast, overexpression of
Cxcl12 in Mist1-CreERT2;H/K-ATPase-Cxcl12;Cdh1flox/flox mice
led to persistence and growth of DGC lesions over 3 months
even without Hf infection (Figures 6I–6K). Hf infection further accelerated DGC progression in this mouse model, while anti-CD90.2
Ab treatment significantly reduced the number of DGC foci in
the setting of Cxcl12 overexpression (Figures S6M and S6N).
Thus, upregulation of Cxcl12/Cxcr4 signaling through activation
of ILCs plays a central role in DGC development.
After Hf infection, Wnt5a is highly upregulated in the stroma
surrounding signet-ring lesions in the isthmus (Figure 6L). In
addition, AMD3100 and anti-CD90.2 Ab treatment, or knock
out of Cxcl12 in Tie2-lineage, significantly decreased the number
of Cxcr4+ cells in the isthmus and the expression of Wnt5a, while
Cxcl12-overexpression led to an increase in Cxcr4+ cell number
and upregulation of Wnt5a (Figures 6M and S6O). Thus, we
tested the contribution of Wnt5a in DGC development by transplanting Cag-CreERT; Wnt5aflox/flox mouse bone marrow cells
into Cdh1DMist1 mice (Figure 6N). In these chimeric mice, E-cadherin is depleted in the Mist1+ lineage and Wnt5a is knocked out
in bone-marrow derived ILCs after TAM induction. Cdh1DMist1

mice with Cag-CreERT;Wnt5aflox/flox bone marrow exhibited
significantly fewer signet-ring cell foci compared to Cdh1DMist1
mice with wild-type (WT) bone marrow cells (Figures 6O and
6P), indicating that Wnt5a in the hematopoietic cells promotes
DGC progression. Although there was a significant increase in
the number of Cxcr4+ cells in the Kras-induced IGC model,
AMD3100 failed to block either Kras or Notch-dependent IGC
progression (Figures S6P and S6Q), suggesting the more predominant role of this pathway in DGC development.
RhoA Activation by Wnt5a Plays a Role in DGC
Development
Wnt5a is known to activate a small GTPase protein, RhoA, which
has a prosurvival effect by inhibiting anoikis in gastric and other
cancer cells (Cai et al., 2008; Liu et al., 2013). Thus, we hypothesized that ILC-derived Wnt5a activates RhoA in E-cadherindepleted cells and prolongs cell survival. We confirmed that
Wnt5a activates RhoA in a CDH1 mutant AGS cells by immunoprecipitation (Figure 7A). In a soft-agar assay, treatment of AGS
cells with Wnt5a enhanced sphere formation, indicating that
Wnt5a promotes anchorage-independent cell growth. Interestingly, blocking RhoA activation using a Rho inhibitor, Rhosin,
diminished Wnt5a-mediated effects (Figures 7B and 7C). Similar
results were observed with another DGC cell line, KATO-III.
Furthermore, we found that E-cadherin-deficient Mist1+ stem
cells, which are normally unable to survive in vitro upon Cdh1
deletion, displayed prolonged survival in the presence of
Wnt5a (Figures 7D and 7E). This prosurvival effect was blocked
by Rhosin, suggesting that Wnt5a-mediated RhoA activation is
a key event for the survival of Cdh1-deleted organoids. However,
Wnt5a did not affect the expansion of Kras or Notch-induced
IGC organoids (data not shown).
We compared these murine DGC findings with human DGC
samples. Histologically, the DGC lesions in the Cdh1DMist1
mice appeared quite similar to early DGC with E-cadherin loss
in patient samples (Figure 7F). Importantly, Cxcl12+ cells were
found in stromal cells that appeared similar histologically to
blood vessels, with KLRG1+ lymphocytes surrounding the signet-ring cancer cells, consistent with a role for these cells in supporting the DGC stem cell niche.
DISCUSSION
In this study, we report four major discoveries regarding gastric
stem cell and cancer biology: (1) quiescent Mist1+ gastric stem

(F) FACS plots of gastric Cxcr4+ cells. The top left image shows gating by CD45+ and Cxcr4-EGFP+. The top middle image shows gating by Lin . The top right
image shows the ILCs are identified by IL-7R+CD90.2+. The bottom image shows the histograms of the indicated ILC markers.
(G) Single-cell culture of Mist1+ cells (red) with or without Cxcr4+ cell (green) co-culture.
(H) Relative colony forming efficiency of Mist1+ cells with Cxcl12 treatment and Cxcr4+ cell co-culture (n = 4/group). The colony formation efficiency of the control
group is set as 1.0 in (H) and (J).
(I) Wnt5a gene expression in Cxcr4+/ ILCs and non-ILC CD45+ cells (n = 3/group).
(J) Relative colony forming efficiency of Mist1+ cells with Wnt5a (100 ng/ml), Cxcr4+ ILCs, or Cag-CreERT;Wnt5aflox/flox ILCs (n = 4/group).
(K) Cxcl12-dsRED mouse stomach with phalloidin staining (green).
(L) Cxcr4-EGFP;Cxcl12-dsRED mouse stomach.
(M) Cell positions of Cxcr4+ cells and Cxcl12+ cells.
(N) Immunostaining (green) of CD31 in Cxcl12+ cells (red).
(O and P) GFP expression (O) and the numbers of GFP+ cells (P) in Cxcr4-EGFP and Tie2-Cre;Cxcl12flox/flox;Cxcr4-EGFP mouse corpus (n = 30/group)
(means ± SEM and *p < 0.05). Scale bars represent 10 mm (B–E, K, and N) and 25 mm (G, L, and O).
See also Figure S4 and Table S1.
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Figure 5. E-cadherin Loss in Mist1+ Cells Develops DGC Dependent on Chronic Inflammation
(A and B) H&E and E-cadherin staining (A) and the location (B) of atypical foci in Cdh1DMist1 mice (day 10).
(C) Numbers of atypical foci per section with or without Hf infection (n = 3 mice/group at each time point).
(D) H&E staining (left) and GFP expression (right) in Hf-infected Mist1-CreERT2;Cdh1flox/flox;R26-mTmG mice 18 months after TAM induction.
(E) Protocols for TAM, Hf, and therapies (dexamethasone, AMD3100, and anti-CD90.2 Ab).
(F and G) H&E staining (F) and numbers of atypical foci per section (G) in Hf-infected Cdh1DMist1 mice treated with or without dexamethasone (n = 4 mice/group
and four sections/mouse are analyzed).
(H–J) Numbers of atypical foci per section (H), H&E (I), and GFP staining (J) in Cdh1DMist1and Cdh1DMist1 mice crossed with H/K-ATPase-IL1b mice after 4 months
TAM induction (means ± SEM and *p < 0.05). Scale bars represent 50 mm.
See also Figure S5.

cells located at the isthmus of the corpus gland are an origin of all
epithelial lineages, (2) they can serve as a cellular origin of all
histological types of gastric cancer, (3) the Cxcl12/Cxcr4 axis
comprising endothelial cells and ILCs regulates the normal and
neoplastic gastric stem cell niche, and (4) Wnt5a from Cxcr4+
ILCs promotes diffuse-type cancer growth by activating RhoA.
Our data provide a focus for gastric regeneration and cancer prevention and therapy.
In the gastric corpus, the isthmus is the major site of epithelial
proliferation and for many years has been thought to contain the
granule free stem cell population (Karam and Leblond, 1993). We
found that the isthmus Mist1+ cells are these granule free bona
fide stem cells in the corpus, which are remarkably quiescent,

dividing infrequently (every 5 days), consistent with the original
expectations for mammalian adult stem cells (Malam and
Cohn, 2014). It has been hypothesized that corpus glands may
possess two different stem cell zones, isthmus and chief cells
(Nam et al., 2010; Stange et al., 2013). Our ablation experiments
using a 5-FU and Lgr5-DT system find that only isthmus cells, not
chief cells, play a predominant role in maintaining the gastric
gland and are an origin of gastric cancer. The gradient of BMP
or Shh expression determines the localized expression of Lgr5
at the gastrointestinal gland base (Shyer et al., 2015) and basal
chief cells in the corpus express Lgr5. Thus, our model suggests
that Lgr5 expression may not always reflect actual stemness,
especially in a Wnt-independent organ.
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Figure 6. Cxcl12/Cxcr4 Perivascular Niche Regulates DGC Progression through Wnt5a Production
(A–E) E-cadherin (A) and CD90.2 staining (B) (red) of Mist1-CreERT2;Cdh1flox/flox;Cxcr4-EGFP (green) mice, and Mist1-CreERT2;Cdh1flox/flox;Cxcl12-dsRED
(red);Cxcr4-EGFP (green) (C) mice treated with TAM and Hf (6 months). The numbers of Cxcl12+ cells (D) and Cxcr4+CD90.2+ cells (E) per gland with or without Hf
infection are shown. The total 20 glands per group were analyzed.
(F–H) H&E staining of Hf-infected Cdh1DMist1 mice treated with or without AMD3100 (F) or treated with control IgG Ab or anti-CD90.2 Ab (G). The numbers of
atypical foci per section (H) (n = 4 mice/group and four sections/mouse are analyzed) are shown. The arrows indicate the atypical foci.
(I–K) H&E (I) and E-cadherin (J) staining and numbers of atypical foci per section (K) in Cdh1DMist1 mice crossed to H/K-ATPase-Cxcl12 mice 3 months after TAM
(n = 3 mice/group and four sections/mouse are analyzed). The arrows indicate the atypical foci.
(L) In situ hybridization of Wnt5a in Cdh1DMist1 mice with or without Hf infection.
(M) Cxcr4-EGFP expression in WT and H/K-ATPase-Cxcl12 mouse stomach treated with control, AMD-3100, or anti-CD90.2 Abs.
(N–P) Control or Cag-CreERT;Wnt5aflox/flox mouse bone marrow cells were transplanted into Mist1-CreERT2;H/K-ATPase-Cxcl12;Cdh1flox/flox mice after 10.5 Gy
whole body irradiation (N). The numbers (O) of atypical foci per section and H&E staining (P) are shown (n = 4 mice/group and four sections/mouse are analyzed).
The arrows indicate the atypical foci (means ± SEM and *p < 0.05). Scale bars represent 50 mm (A–C, F, G, L, and M) and 100 mm (I, J, and P).
See also Figure S6.
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Figure 7. RhoA Activation by Wnt5a Plays a Role in DGC Development
(A) AGS cells were treated with 100 ng/ml Wnt5a for the indicated times. The cell lysates were immunoprecipitated with RhoA-GTP Ab and immunoblotted with
total RhoA Ab.
(B and C) Soft-agar sphere forming assay of Wnt5a-treated AGS and KATO-III cells. The cells were treated with vehicle or 30 mM Rhosin. The sphere images (B)
and numbers (C) of spheres at day 10 are shown (n = 4/group).
(D and E) Corpus organoids from TAM-treated Mist1-CreERT2;Cdh1flox/flox;R26-mTmG mice treated with 100 ng/ml Wnt5a and/or 30 mM Rhosin. The images (D)
and numbers (E) of GFP+Cdh1 organoids per total organoid number on days 3 and 14 are shown (n = 4/group).
(F) H&E, E-cadherin, Cxcl12, and KLRG1 staining in human DGC. Scale bars represent 100 mm (D) and 50 mm (B and F) (means ± SEM and *p < 0.05).

Lineage-tracing studies have been based largely on TAMinduced Cre activation, but TAM treatment may cause epithelial
cell death and influence stem cell activity (Huh et al., 2012; Zhu
et al., 2013). Given that Troy is known to have an inhibitory effect
on Wnt signaling, the knockin Troy lineage tracing may be related
to a reduction in Troy expression in the knockin mice, secondary
to haploinsufficiency, resulting in enhanced Wnt signaling activity in those mice. While knockin lines have many potential advantages, disruption of even one copy of the endogenous gene can
apparently alter certain phenotypes.
The Cxcl12/Cxcr4 perivascular niche in the bone marrow was
previously identified and studied as a major regulator of HSC
(Ding and Morrison, 2013; Sugiyama et al., 2006). However, until
now the role of the Cxcl12/Cxcr4 stem cell niche axis beyond the
bone marrow has been unclear. In addition, Cxcl12 and Cxcr4
modulate the tumor microenvironment and targeting this axis
was an effective strategy in certain cancers (Pitt et al., 2015;
Quante et al., 2011; Roccaro et al., 2014). Given that human

DGCs are in general extremely resistant to current treatment regimens, anti-inflammatory drugs such as steroids or non-steroidal
anti-inflammatory drugs (NSAIDs), as well as specific Cxcr4 antagonists, may be useful for chemoprevention of DGC, particularly for hereditary-type DGC prior to gastrectomy, and/or for
prevention of recurrent disease.
E-cadherin is essential for epithelial cell survival under
normal conditions (Schneider et al., 2010) and loss of E-cadherin causes cell anoikis (Kantak and Kramer, 1998). Previous
studies suggest that Cxcr4 and Wnt5a are upregulated in
human gastric cancer tissues (Iwasa et al., 2009; Kanzawa
et al., 2013). Recent genome-wide analyses revealed in human
DGCs the presence of gain-of-function RHOA mutations
that can inhibit anoikis (Cancer Genome Atlas Research
Network, 2014; Kakiuchi et al., 2014; Wang et al., 2014).
Thus, the activation of RhoA signaling, either by gene mutation
or Wnt5a-mediated effect, may be essential for the development of DGC.

Cancer Cell 28, 800–814, December 14, 2015 ª2015 Elsevier Inc. 811

Wnt5a is a representative ligand that activates non-canonical
Wnt signaling by binding to Ror2 to regulate cell migration, polarity, proliferation, or invasion. Wnt5a is expressed in gut stroma
and contributes to intestinal elongation and colonic regeneration, however, the precise source of stromal Wnt5a has been unclear (Cervantes et al., 2009; Gregorieff et al., 2005; Miyoshi
et al., 2012). We propose ILCs as a major source of Wnt5a, at
least in the stomach. The function of ILCs has been highlighted
in the setting of inflammatory or infectious states, although the
possibility has been raised of a role for ILCs in stem cell niche
or cancer development (Bando et al., 2015; Hanash et al.,
2012; Kirchberger et al., 2013). Our findings would support this
model, and given that ILCs are a heterogeneous population of
immune cells, further efforts at detailed profiling of the ILC population in stem cell niche and cancer are needed.
EXPERIMENTAL PROCEDURES
Mice
Mist1-CreERT2 mice (Shi et al., 2009), Cxcl12-dsRED mice (Ding and Morrison, 2013), Troy / and Troy-BAC-CreERT2 mice (Fafilek et al., 2013), H/KATPase-Cxcl12 mice (Shibata et al., 2013), Eef1a1-LSL-Notch1(IC) mice (Buonamici et al., 2009), and Wnt5aflox mice (Miyoshi et al., 2012) were described
previously. Cxcr4-EGFP mice were kindly provided by Richard J. Miller (Northwestern University Medical School). LSL-KrasG12D and LSL-Trp53R172H mice
were provided by Dr. Kenneth Olive (Columbia University). Apcflox mice were
obtained from the National Cancer Institute (NCI). Lgr5-DTR-GFP mice were
provided by Genentech. Cdh1flox, R26-mTmG, R26-LacZ, R26-TdTomato,
R26-Confetti, R26-EYFP, Cxcl12flox, Tie2-Cre, Id2-GFP, and Cag-CreERT
mice were purchased from the Jackson Laboratory. Cre recombinase was
activated by oral administration of TAM (1–5 mg/0.2 ml corn oil, as indicated).
All animal studies and procedures were approved by the ethics committees at
Columbia University and the Academy of Sciences of the Czech Republic.
Human stomach tissue sections were obtained from DGC patients who
underwent surgical resection or endoscopic submucosal dissection from
2001 to 2012 at Gifu University Hospital, Gifu, Japan. All study protocols
were approved by the ethics committees, and written informed consent was
obtained from all patients.
Treatment
5-FU (Sigma) was administered intraperitoneally (i.p.) at a dose of 150 mg/kg.
DMP-777 was given as described previously (Nam et al., 2010). DBZ was
dissolved in 10% dimethyl sulfoxide and injected i.p. (30 mmol/kg) for
14 days. For Lgr5+ cell ablation, DT was administered i.p. at a dose of
20 mg/kg. Mice were treated with 5 mg/kg AMD3100 (Tocris) to inhibit
Cxcr4 for 2 weeks, as described previously (Quante et al., 2011). Dexamethasone (Sigma) was administered i.p. at a dose of 5 mg/kg for 2 weeks. CD90.2
mAb (30H12) (BioXCell) was administered i.p. every 2 days at a dose of
250 mg/mouse for 4 weeks. Control groups were treated with appropriate vehicles or control antibodies.

ducted the pathological evaluation of mice. W.S. and M.D.G. performed electron microscopy. L.D. and S.F.K. provided the mice. S.S. assisted in situ
hybridization and adenovirus injection experiments. Y.H., H.A., S.A., C.B.W.,
L.D., J.G.F., R.A.F., D.L.W., V.K., and T.C.W. wrote the manuscript and
contributed to the study supervision and coordination as well as to the performance of the experiments.
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